The Cochrane Heart Group registered as an entity of the Cochrane Collaboration in July 1998.

The Cochrane Heart Group’s aim is to prepare, maintain and promote the access of systematic reviews of the effects of  interventions for treating ischaemic and all other heart diseases and preventing cardiovascular diseases. We also aim to make the results of research assessing the effects of health care on heart diseases more easily available and more relevant to health care professionals, policy makers and to the general public.

The scope of the Cochrane Heart Group includes primary prevention, acute treatment, secondary prevention and rehabilitation, in all forms of heart disease, including ischaemic heart disease, heart diseases more common in developing countries, arrhythmias, valvular and congenital heart diseases.

The Group has a wide membership including clinicians, researchers and healthcare consumers from all over the world. Our members share an interest in generating reliable, up-to-date evidence relevant to the prevention, treatment and rehabilitation of particular heart problems or groups of problems.

We are based at the Department of Non-Communicable Disease Epidemiology, London School of Hygiene & Tropical Medicine, UK.